Xenon Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Xenon Pharmaceuticals patents 45 in total

Status Patent
Application
Utility: METHODS AND USES FOR TREATING ANHEDONIA External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: METHODS FOR TREATING ABSENCE SEIZURES External link
Filling date: 6 Sep 2025 Issue date: 23 Jun 2022
Grant
Utility: Benzenesulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Benzenesulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 12 Apr 2022
Application
Utility: METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 24 Feb 2022
Grant
Utility: Substituted benzamides and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Benzenesulfonamide compouds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 16 Nov 2021
Grant
Utility: Therapeutic compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 19 Oct 2021
Grant
Utility: Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener External link
Filling date: 6 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Therapeutic compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 28 Sep 2021
Application
Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Aug 2021
Grant
Utility: Solid state crystalline forms of a selective potassium channel modulator External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Application
Utility: METHODS OF TREATING PAIN External link
Filling date: 6 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OPENER EZOGABINE External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: METHODS OF TREATING DEPRESSIVE DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 27 May 2021
Application
Utility: SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR External link
Filling date: 6 Sep 2025 Issue date: 20 May 2021
Grant
Utility: Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Application
Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 18 Mar 2021
Grant
Utility: Substituted benzamides useful as sodium channel blockers External link
Filling date: 6 Sep 2025 Issue date: 26 Jan 2021
Application
Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS External link
Filling date: 6 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS External link
Filling date: 6 Sep 2025 Issue date: 12 Nov 2020
Grant
Utility: Benzenesulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 27 Oct 2020
Grant
Utility: Therapeutic compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: Substituted benzamides and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Benzenesulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Benzenesulfonamide compounds and their use as therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 26 May 2020
Application
Utility: HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS External link
Filling date: 6 Sep 2025 Issue date: 21 May 2020
Application
Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 16 Apr 2020
Application
Utility: SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS External link
Filling date: 6 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: METHOD FOR TREATING EPILEPSY External link
Filling date: 6 Sep 2025 Issue date: 30 Jan 2020
Grant
Utility: Therapeutic compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Solid state forms of spiro-oxindole compounds External link
Filling date: 6 Sep 2025 Issue date: 24 Dec 2019
Application
Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS External link
Filling date: 6 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER External link
Filling date: 6 Sep 2025 Issue date: 14 Nov 2019
Grant
Utility: Therapeutic compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2019

Showing 1 to 45 of 45 patents.